NYSE:TMO - Thermo Fisher Scientific Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $481.13
  • Forecasted Upside: 7.87 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$446.03
▼ -5.01 (-1.11%)
1 month | 3 months | 12 months
Get New Thermo Fisher Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TMO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TMO

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$481.13
▲ +7.87% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Thermo Fisher Scientific in the last 3 months. The average price target is $481.13, with a high forecast of $550.00 and a low forecast of $340.00. The average price target represents a 7.87% upside from the last price of $446.03.
Buy
The current consensus among 17 contributing investment analysts is to buy stock in Thermo Fisher Scientific. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/2/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/31/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/29/2019
  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/27/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/27/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/25/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/23/2020

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$550.00High
i
10/27/2020Needham & Company LLCBoost Price TargetBuy$477.00 ➝ $539.00Low
i
Rating by Stephen Unger at Needham & Company LLC
10/22/2020BTIG ResearchBoost Price TargetPositive ➝ Buy$475.00 ➝ $540.00High
i
10/22/2020Robert W. BairdBoost Price TargetOutperform$481.00 ➝ $512.00High
i
10/22/2020Credit Suisse GroupBoost Price TargetNeutral$432.00 ➝ $488.00High
i
10/22/2020Morgan StanleyBoost Price TargetOverweight$485.00 ➝ $535.00High
i
10/22/2020SVB LeerinkBoost Price TargetOutperform$470.00 ➝ $525.00High
i
10/5/2020JPMorgan Chase & Co.Boost Price TargetOverweight$460.00 ➝ $480.00High
i
9/30/2020Atlantic SecuritiesInitiated CoverageOverweight$494.00Medium
i
9/17/2020Needham & Company LLCBoost Price TargetBuy$468.00 ➝ $477.00Low
i
Rating by Stephen Unger at Needham & Company LLC
9/14/2020Morgan StanleyInitiated CoverageOverweight$485.00Low
i
9/11/2020Bank of AmericaBoost Price TargetBuy$460.00 ➝ $480.00Low
i
9/11/2020Credit Suisse GroupBoost Price TargetNeutral$425.00 ➝ $432.00Low
i
9/11/2020SVB LeerinkBoost Price TargetOutperform$455.00 ➝ $470.00Medium
i
9/11/2020CitigroupBoost Price TargetBuy$471.00 ➝ $485.00Medium
i
8/21/2020Credit Suisse GroupBoost Price TargetNeutral$405.00 ➝ $425.00Medium
i
8/20/2020JPMorgan Chase & Co.Reiterated RatingOverweight$460.00Low
i
8/13/2020Needham & Company LLCInitiated CoverageBuy$468.00Low
i
Rating by Stephen Unger at Needham & Company LLC
7/27/2020ArgusBoost Price Target$370.00 ➝ $450.00Low
i
7/23/2020Robert W. BairdBoost Price Target$352.00 ➝ $436.00Low
i
7/23/2020Needham & Company LLCBoost Price TargetBuy$415.00 ➝ $468.00Low
i
Rating by Stephen Unger at Needham & Company LLC
7/23/2020BTIG ResearchBoost Price TargetBuy$372.00 ➝ $475.00Low
i
7/23/2020CitigroupBoost Price TargetBuy$390.00 ➝ $471.00Low
i
7/23/2020Stifel NicolausBoost Price TargetHold ➝ Buy$370.00 ➝ $460.00Low
i
7/23/2020SVB LeerinkBoost Price TargetOutperform$365.00 ➝ $455.00Low
i
7/21/2020UBS GroupBoost Price TargetBuy$385.00 ➝ $440.00High
i
7/15/2020Cleveland ResearchUpgradeNeutral ➝ BuyLow
i
7/7/2020Needham & Company LLCBoost Price TargetBuy$383.00 ➝ $415.00Low
i
Rating by Stephen Unger at Needham & Company LLC
7/6/2020CowenReiterated RatingBuy$380.00Low
i
Rating by Doug Schenkel at Cowen Inc
4/23/2020CitigroupBoost Price TargetBuy$365.00 ➝ $390.00High
i
4/23/2020SVB LeerinkBoost Price TargetOutperform$330.00 ➝ $365.00High
i
4/23/2020Needham & Company LLCBoost Price Target$341.00 ➝ $383.00High
i
Rating by Stephen Unger at Needham & Company LLC
4/22/2020Needham & Company LLCBoost Price TargetBuy$341.00 ➝ $383.00Medium
i
4/21/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$300.00 ➝ $340.00High
i
4/2/2020Stifel NicolausLower Price TargetBuy$345.00 ➝ $315.00Medium
i
3/30/2020Wells Fargo & CompanyLower Price TargetEqual Weight$345.00 ➝ $300.00Medium
i
3/20/2020CitigroupLower Price TargetBuy$390.00 ➝ $365.00Low
i
3/4/2020Robert W. BairdBoost Price TargetOutperform$340.00 ➝ $341.00High
i
2/24/2020ArgusReiterated RatingBuy ➝ Positive$370.00High
i
1/31/2020BTIG ResearchBoost Price TargetBuy ➝ In-Line$342.00 ➝ $372.00High
i
1/31/2020Robert W. BairdBoost Price TargetOutperform$319.00 ➝ $340.00High
i
1/31/2020Wells Fargo & CompanyLower Price TargetEqual Weight$350.00 ➝ $345.00High
i
1/31/2020Needham & Company LLCBoost Price TargetBuy$331.00 ➝ $341.00High
i
1/31/2020CitigroupBoost Price TargetBuy$380.00 ➝ $390.00High
i
1/22/2020Credit Suisse GroupInitiated CoverageNeutral$341.00Low
i
1/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$350.00Low
i
1/6/2020CitigroupInitiated CoverageBuy$380.00Low
i
1/6/2020CowenReiterated RatingOutperform$330.00 ➝ $365.00Medium
i
1/3/2020Needham & Company LLCInitiated CoverageStrong-Buy$271.00Medium
i
11/14/2019Stifel NicolausInitiated CoverageBuy$345.00Medium
i
11/14/2019Evercore ISIUpgradeOutperformHigh
i
10/24/2019Robert W. BairdBoost Price TargetOutperform$305.00 ➝ $319.00Low
i
10/23/2019JPMorgan Chase & Co.Boost Price TargetOverweight$315.00 ➝ $330.00Low
i
7/31/2019Credit Suisse GroupReiterated RatingBuy$310.00Low
i
7/25/2019Needham & Company LLCBoost Price TargetBuy ➝ Buy$315.00 ➝ $321.00Low
i
Rating by Stephen Unger at Needham & Company LLC
7/16/2019Needham & Company LLCDowngradeStrong-Buy ➝ Buy$315.00Low
i
Rating by Stephen Unger at Needham & Company LLC
7/15/2019BarclaysSet Price TargetBuy$330.00Medium
i
Rating by Jack Meehan at Barclays PLC
5/30/2019Wolfe ResearchInitiated CoverageOutperform ➝ OutperformLow
i
5/23/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$313.00 ➝ $315.00Low
i
Rating by Stephen Unger at Needham & Company LLC
5/23/2019BTIG ResearchBoost Price TargetAverage ➝ Buy$320.00Low
i
5/23/2019UBS GroupBoost Price TargetBuy$305.00 ➝ $320.00Low
i
5/1/2019ArgusBoost Price TargetBuy ➝ Buy$285.00 ➝ $310.00Low
i
4/22/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$271.00 ➝ $312.00Low
i
4/16/2019Bank of AmericaReiterated RatingBuy ➝ Buy$285.00 ➝ $300.00High
i
3/26/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$270.00 ➝ $288.00Low
i
3/26/2019BTIG ResearchBoost Price TargetBuy$310.00Low
i
3/25/2019UBS GroupBoost Price TargetBuy$305.00High
i
Rating by Daniel Brennan at UBS Group AG
3/22/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$275.00 ➝ $300.00High
i
3/18/2019BarclaysBoost Price TargetOverweight ➝ Overweight$295.00 ➝ $300.00Low
i
1/31/2019BTIG ResearchBoost Price TargetBuy$290.00Medium
i
1/30/2019Robert W. BairdBoost Price TargetOutperform$264.00 ➝ $270.00Low
i
1/3/2019BarclaysBoost Price TargetOverweight ➝ Overweight$275.00 ➝ $280.00Low
i
1/2/2019Needham & Company LLCInitiated CoverageStrong-Buy ➝ Strong-Buy$271.00High
i
10/25/2018Morgan StanleyBoost Price TargetOverweight$254.00 ➝ $260.00Low
i
10/25/2018Robert W. BairdBoost Price TargetOutperform$256.00 ➝ $264.00Low
i
10/18/2018Cleveland ResearchDowngradeBuy ➝ NeutralMedium
i
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$242.00 ➝ $254.00High
i
10/10/2018CitigroupBoost Price TargetBuy ➝ Buy$260.00 ➝ $280.00High
i
10/9/2018UBS GroupInitiated CoverageBuy ➝ Buy$295.00Low
i
9/24/2018BarclaysBoost Price TargetOverweight ➝ Overweight$250.00 ➝ $275.00Low
i
9/17/2018The Goldman Sachs GroupDowngradeBuy ➝ NeutralMedium
i
7/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$233.00 ➝ $242.00Low
i
7/26/2018SVB LeerinkBoost Price TargetOutperform$239.00 ➝ $255.00Medium
i
7/26/2018JPMorgan Chase & Co.Reiterated RatingOverweight$300.00Medium
i
7/13/2018Morgan StanleyBoost Price TargetOverweight$230.00 ➝ $233.00Low
i
4/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$216.00 ➝ $230.00Low
i
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$228.00 ➝ $216.00Low
i
2/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$235.00 ➝ $250.00Low
i
2/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$223.00 ➝ $227.00Low
i
2/1/2018BarclaysBoost Price TargetOverweight ➝ Overweight$225.00 ➝ $245.00Low
i
2/1/2018SVB LeerinkReiterated RatingOutperform$200.00 ➝ $239.00Low
i
1/5/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$230.00Medium
i
Rating by Sung Ji Nam at BTIG Research
1/3/2018Evercore ISIInitiated CoverageOutperform$220.00Medium
i
12/4/2017SVB LeerinkReiterated RatingOutperform$216.00 ➝ $200.00High
i
10/30/2017SVB LeerinkReiterated RatingBuyN/A
i
10/26/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$216.00 ➝ $226.00N/A
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
10/9/2017SVB LeerinkBoost Price TargetOutperform$190.00 ➝ $207.00N/A
i
Rating by Puneet Souda at SVB Leerink LLC
9/28/2017Jefferies Financial GroupReiterated RatingHold$195.00Low
i
9/26/2017The Goldman Sachs GroupInitiated CoverageBuy$225.00Low
i
9/25/2017BarclaysReiterated RatingOverweight$200.00 ➝ $215.00Low
i
Rating by Jack Meehan at Barclays PLC
9/10/2017CowenReiterated RatingOutperform$200.00 ➝ $220.00Low
i
9/6/2017Morgan StanleyReiterated RatingOverweight ➝ Overweight$220.00Medium
i
9/1/2017CowenReiterated RatingBuy$200.00Low
i
8/22/2017ArgusReiterated RatingBuyMedium
i
7/21/2017Bank of AmericaReiterated RatingBuy$200.00 ➝ $210.00Low
i
7/20/2017Cleveland ResearchUpgradeNeutral ➝ BuyLow
i
7/17/2017BarclaysReiterated RatingOverweight$190.00 ➝ $200.00Low
i
Rating by Jack Meehan at Barclays PLC
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 ➝ $200.00Low
i
7/10/2017CitigroupReiterated RatingBuy$182.00 ➝ $201.00Low
i
6/10/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$200.00Low
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$194.00Low
i
Rating by B. Brokmeier at Cantor Fitzgerald
5/17/2017Jefferies Financial GroupReiterated RatingHold$175.00Low
i
5/9/2017BarclaysReiterated RatingOverweight ➝ Overweight$175.00 ➝ $190.00Low
i
Rating by Jack Meehan at Barclays PLC
5/9/2017Bank of AmericaBoost Price TargetBuy$190.00 ➝ $200.00Low
i
4/29/2017CowenReiterated RatingOutperform$175.00 ➝ $185.00Low
i
4/28/2017Morgan StanleyBoost Price TargetOverweight$186.00 ➝ $192.00Low
i
4/28/2017Jefferies Financial GroupBoost Price TargetHold$160.00 ➝ $175.00Low
i
4/28/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$163.00 ➝ $188.00Low
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 ➝ $190.00Low
i
4/27/2017SVB LeerinkSet Price TargetBuy$187.00Low
i
Rating by Puneet Souda at SVB Leerink LLC
4/26/2017BarclaysSet Price TargetBuy$175.00Low
i
Rating by Jack Meehan at Barclays PLC
3/29/2017Jefferies Financial GroupReiterated RatingHold$160.00Low
i
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 ➝ $162.00N/A
i
1/23/2017Jefferies Financial GroupLower Price TargetHold$163.00 ➝ $160.00N/A
i
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$163.00N/A
i
12/12/2016The Goldman Sachs GroupReiterated RatingConviction-Buy ➝ Conviction-Buy$170.00 ➝ $168.00N/A
i
11/20/2016SVB LeerinkReiterated RatingBuy$175.00N/A
i
Rating by P. Souda at SVB Leerink LLC
11/10/2016SVB LeerinkInitiated CoverageOutperform$175.00N/A
i
Rating by Dan Leonard at SVB Leerink LLC
10/7/2016Bank of AmericaSet Price TargetBuy$180.00N/A
i
Rating by Derik De Bruin at Bank of America Co.
9/27/2016UBS GroupReiterated RatingBuy$176.00N/A
i
9/22/2016JPMorgan Chase & Co.Initiated CoverageOverweight$180.00N/A
i
9/21/2016UBS GroupBoost Price TargetBuy$170.00 ➝ $176.00N/A
i
9/9/2016Cleveland ResearchDowngradeBuy ➝ NeutralN/A
i
8/4/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
Rating by Brandon Couillard at Jefferies Financial Group Inc.
7/29/2016CitigroupBoost Price TargetBuy$160.00 ➝ $182.00N/A
i
7/28/2016MizuhoSet Price TargetBuy$170.00 ➝ $175.00N/A
i
Rating by Eric Criscuolo at Mizuho
7/22/2016BTIG ResearchUpgradeNeutral ➝ Buy$180.00N/A
i
Rating by Dane Leone at BTIG Research
7/6/2016The Goldman Sachs GroupReiterated RatingBuyN/A
i
5/29/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Dan Leonard at SVB Leerink LLC
5/27/2016MizuhoBoost Price TargetBuy$166.00 ➝ $170.00N/A
i
Rating by Eric Criscuolo at Mizuho
5/27/2016BTIG ResearchReiterated RatingNeutralN/A
i
5/19/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Steve Beuchaw at Morgan Stanley
5/19/2016MizuhoReiterated RatingBuy$163.00 ➝ $166.00N/A
i
Rating by Eric Criscuolo at Mizuho
5/11/2016Bank of AmericaReiterated RatingBuy$163.00N/A
i
5/3/2016MizuhoReiterated RatingBuy$160.00 ➝ $163.00N/A
i
Rating by Eric Criscuolo at Mizuho
4/30/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Steve Beuchaw at Morgan Stanley
4/30/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Dan Leonard at SVB Leerink LLC
4/29/2016UBS GroupReiterated RatingBuy$170.00N/A
i
4/29/2016Jefferies Financial GroupDowngradeBuy ➝ HoldN/A
i
4/4/2016MizuhoBoost Price TargetBuy$150.00 ➝ $160.00N/A
i
3/23/2016The Goldman Sachs GroupBoost Price Target$156.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
3/21/2016UBS GroupReiterated RatingBuy$170.00N/A
i
3/21/2016SVB LeerinkReiterated RatingOutperformN/A
i
3/21/2016Evercore ISIReiterated RatingBuy$145.00N/A
i
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 ➝ $155.00N/A
i
1/31/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by Shawn Bevec at Deutsche Bank Aktiengesellschaft
1/31/2016BTIG ResearchReiterated RatingNeutralN/A
i
1/29/2016UBS GroupLower Price TargetBuy$175.00 ➝ $170.00N/A
i
1/29/2016Stifel NicolausLower Price Target$158.00 ➝ $150.00N/A
i
1/29/2016MizuhoLower Price TargetBuy$150.00N/A
i
1/29/2016SVB LeerinkLower Price TargetOutperform$149.00 ➝ $141.00N/A
i
1/29/2016KeyCorpLower Price TargetOverweight$152.00 ➝ $150.00N/A
i
1/29/2016Deutsche Bank AktiengesellschaftLower Price Target$160.00 ➝ $152.00N/A
i
Rating by Shawn Bevec at Deutsche Bank Aktiengesellschaft
1/29/2016BarclaysLower Price TargetOverweight$165.00 ➝ $160.00N/A
i
1/13/2016BTIG ResearchReiterated RatingNeutralN/A
i
1/11/2016Stifel NicolausBoost Price TargetBuy$150.00 ➝ $158.00N/A
i
1/7/2016CowenBoost Price Target$160.00N/A
i
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00N/A
i
1/6/2016Deutsche Bank AktiengesellschaftInitiated CoverageBuy$160.00N/A
i
12/8/2015The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$146.00 ➝ $158.00N/A
i
11/24/2015The Goldman Sachs GroupLower Price TargetBuy$148.00 ➝ $146.00N/A
i
(Data available from 11/24/2015 forward)
Thermo Fisher Scientific logo
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; an agreement with Daiichi Sankyo; and collaboration with Northeastern University. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $446.03
$441.76
$455.92

50 Day Range

MA: $475.04
$435.06
$527.66

52 Week Range

Now: $446.03
$250.21
$532.57

Volume

2,111,835 shs

Average Volume

1,677,275 shs

Market Capitalization

$176.78 billion

P/E Ratio

48.27

Dividend Yield

0.20%

Beta

0.98